{"nct_id":"NCT03715205","title":"Study to Evaluate the Safety of Pembrolizumab in Participants With Unresectable or Metastatic Melanoma or Non-small Cell Lung Cancer in India (MK-3475-593/KEYNOTE-593)","status":"COMPLETED","status_verified_date":"2025-08","start_date":"2019-01-31","start_date_type":"ACTUAL","primary_completion_date":"2024-08-21","primary_completion_date_type":"ACTUAL","completion_date":"2024-08-21","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["MRK"]}